AVDL Annual D&A
$1.77 M
+$273.00 K+18.29%
31 December 2023
Summary:
As of January 23, 2025, AVDL annual depreciation & amortization is $1.77 million, with the most recent change of +$273.00 thousand (+18.29%) on December 31, 2023. During the last 3 years, it has risen by +$76.00 thousand (+4.50%). AVDL annual D&A is now -87.81% below its all-time high of $14.49 million, reached on December 31, 2016.AVDL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Quarterly D&A
$1.03 M
+$598.00 K+136.84%
30 September 2024
Summary:
As of January 23, 2025, AVDL quarterly depreciation & amortization is $1.03 million, with the most recent change of +$598.00 thousand (+136.84%) on September 30, 2024. Over the past year, it has increased by +$1.05 million (+5850.00%). AVDL quarterly D&A is now -73.64% below its all-time high of $3.93 million, reached on June 30, 2016.AVDL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL TTM D&A
$2.00 M
+$440.00 K+28.30%
30 September 2024
Summary:
As of January 23, 2025, AVDL TTM depreciation & amortization is $2.00 million, with the most recent change of +$440.00 thousand (+28.30%) on September 30, 2024. Over the past year, it has increased by +$229.00 thousand (+12.97%). AVDL TTM D&A is now -86.60% below its all-time high of $14.89 million, reached on September 30, 2016.AVDL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.3% | +5850.0% | +13.0% |
| 3 y3 years | +4.5% | +72.2% | -8.3% |
| 5 y5 years | -76.2% | +72.2% | -8.3% |
AVDL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.7% | at high | +5850.0% | -15.8% | +144.8% |
| 5 y | 5-year | -29.0% | +116.7% | at high | +5850.0% | -22.5% | +144.8% |
| alltime | all time | -87.8% | +152.3% | -73.6% | +5850.0% | -86.6% | +897.5% |
Avadel Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.03 M(+136.8%) | $2.00 M(+28.3%) |
| June 2024 | - | $437.00 K(-19.2%) | $1.55 M(-9.5%) |
| Mar 2024 | - | $541.00 K(-3105.6%) | $1.72 M(-2.7%) |
| Dec 2023 | $1.77 M(+18.3%) | -$18.00 K(-103.0%) | $1.77 M(-25.5%) |
| Sept 2023 | - | $595.00 K(-1.0%) | $2.37 M(+8.9%) |
| June 2023 | - | $601.00 K(+2.2%) | $2.18 M(+19.4%) |
| Mar 2023 | - | $588.00 K(+0.3%) | $1.82 M(+22.0%) |
| Dec 2022 | $1.49 M(+83.2%) | $586.00 K(+46.1%) | $1.49 M(+34.7%) |
| Sept 2022 | - | $401.00 K(+62.3%) | $1.11 M(+22.6%) |
| June 2022 | - | $247.00 K(-4.6%) | $904.00 K(+5.6%) |
| Mar 2022 | - | $259.00 K(+28.9%) | $856.00 K(+5.0%) |
| Dec 2021 | $815.00 K(-51.8%) | $201.00 K(+2.0%) | $815.00 K(-19.1%) |
| Sept 2021 | - | $197.00 K(-1.0%) | $1.01 M(-11.0%) |
| June 2021 | - | $199.00 K(-8.7%) | $1.13 M(-22.0%) |
| Mar 2021 | - | $218.00 K(-44.5%) | $1.45 M(-14.1%) |
| Dec 2020 | $1.69 M(-32.0%) | $393.00 K(+22.0%) | $1.69 M(-19.3%) |
| Sept 2020 | - | $322.00 K(-38.0%) | $2.09 M(-12.7%) |
| June 2020 | - | $519.00 K(+13.8%) | $2.40 M(-6.8%) |
| Mar 2020 | - | $456.00 K(-42.7%) | $2.57 M(+3.5%) |
| Dec 2019 | $2.49 M(-66.5%) | $796.00 K(+27.2%) | $2.49 M(-28.9%) |
| Sept 2019 | - | $626.00 K(-9.9%) | $3.50 M(-25.4%) |
| June 2019 | - | $695.00 K(+88.3%) | $4.68 M(-19.4%) |
| Mar 2019 | - | $369.00 K(-79.6%) | $5.81 M(-21.7%) |
| Dec 2018 | $7.43 M(+52.2%) | $1.80 M(-0.6%) | $7.43 M(-5.3%) |
| Sept 2018 | - | $1.81 M(-0.5%) | $7.84 M(+10.8%) |
| June 2018 | - | $1.82 M(-8.1%) | $7.08 M(+17.4%) |
| Mar 2018 | - | $1.99 M(-10.5%) | $6.03 M(+23.5%) |
| Dec 2017 | $4.88 M(-66.3%) | $2.22 M(+110.7%) | $4.88 M(-12.8%) |
| Sept 2017 | - | $1.05 M(+36.0%) | $5.60 M(-33.5%) |
| June 2017 | - | $774.00 K(-7.5%) | $8.42 M(-27.2%) |
| Mar 2017 | - | $837.00 K(-71.5%) | $11.57 M(-20.1%) |
| Dec 2016 | $14.49 M(+10.3%) | $2.93 M(-24.3%) | $14.49 M(-2.7%) |
| Sept 2016 | - | $3.87 M(-1.3%) | $14.89 M(+4.2%) |
| June 2016 | - | $3.93 M(+4.6%) | $14.28 M(+4.8%) |
| Mar 2016 | - | $3.75 M(+12.7%) | $13.63 M(+3.8%) |
| Dec 2015 | $13.13 M(-7.1%) | $3.33 M(+1.9%) | $13.13 M(-1.3%) |
| Sept 2015 | - | $3.27 M(-0.1%) | $13.30 M(-1.1%) |
| June 2015 | - | $3.27 M(+0.3%) | $13.46 M(-2.7%) |
| Mar 2015 | - | $3.26 M(-6.9%) | $13.83 M(-2.2%) |
| Dec 2014 | $14.14 M(+361.8%) | $3.50 M(+2.3%) | $14.14 M(+24.5%) |
| Sept 2014 | - | $3.42 M(-6.1%) | $11.36 M(+30.6%) |
| June 2014 | - | $3.65 M(+2.1%) | $8.69 M(+49.6%) |
| Mar 2014 | - | $3.57 M(+396.5%) | $5.81 M(+89.7%) |
| Dec 2013 | $3.06 M(-3.8%) | $719.00 K(-5.3%) | $3.06 M(-3.7%) |
| Sept 2013 | - | $759.00 K(-0.4%) | $3.18 M(-1.6%) |
| June 2013 | - | $762.00 K(-7.3%) | $3.23 M(-1.9%) |
| Mar 2013 | - | $822.00 K(-1.8%) | $3.30 M(+3.6%) |
| Dec 2012 | $3.18 M | $837.00 K(+3.1%) | $3.18 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $812.00 K(-1.7%) | $3.04 M(+3.2%) |
| June 2012 | - | $826.00 K(+16.7%) | $2.94 M(-2.8%) |
| Mar 2012 | - | $708.00 K(+2.8%) | $3.03 M(-9.6%) |
| Dec 2011 | $3.35 M(-28.7%) | $689.00 K(-3.9%) | $3.35 M(-12.6%) |
| Sept 2011 | - | $717.00 K(-21.4%) | $3.83 M(-10.0%) |
| June 2011 | - | $912.00 K(-11.3%) | $4.25 M(-5.0%) |
| Mar 2011 | - | $1.03 M(-12.2%) | $4.48 M(-4.7%) |
| Dec 2010 | $4.70 M(-20.6%) | $1.17 M(+2.5%) | $4.70 M(-12.4%) |
| Sept 2010 | - | $1.14 M(+0.5%) | $5.36 M(+0.5%) |
| June 2010 | - | $1.14 M(-8.9%) | $5.34 M(-6.2%) |
| Mar 2010 | - | $1.25 M(-32.1%) | $5.69 M(-3.9%) |
| Dec 2009 | $5.92 M(-18.4%) | $1.84 M(+64.6%) | $5.92 M(+2.1%) |
| Sept 2009 | - | $1.12 M(-24.9%) | $5.79 M(-9.8%) |
| June 2009 | - | $1.49 M(+0.7%) | $6.42 M(-9.3%) |
| Mar 2009 | - | $1.48 M(-13.8%) | $7.08 M(-2.4%) |
| Dec 2008 | $7.25 M(+17.0%) | $1.71 M(-1.7%) | $7.25 M(+0.7%) |
| Sept 2008 | - | $1.74 M(-18.6%) | $7.20 M(+3.1%) |
| June 2008 | - | $2.14 M(+30.0%) | $6.99 M(+9.7%) |
| Mar 2008 | - | $1.65 M(-1.1%) | $6.37 M(+2.7%) |
| Dec 2007 | $6.20 M(+9.9%) | $1.67 M(+9.0%) | $6.20 M(-3.9%) |
| Sept 2007 | - | $1.53 M(+0.1%) | $6.45 M(+3.9%) |
| June 2007 | - | $1.53 M(+3.2%) | $6.21 M(+6.4%) |
| Mar 2007 | - | $1.48 M(-23.0%) | $5.84 M(+3.5%) |
| Dec 2006 | $5.64 M(+18.9%) | $1.92 M(+49.1%) | $5.64 M(+14.5%) |
| Sept 2006 | - | $1.29 M(+11.8%) | $4.92 M(+0.6%) |
| June 2006 | - | $1.15 M(-9.9%) | $4.90 M(-4.9%) |
| Mar 2006 | - | $1.28 M(+6.1%) | $5.15 M(+8.6%) |
| Dec 2005 | $4.74 M(+87.5%) | $1.21 M(-4.3%) | $4.74 M(+7.8%) |
| Sept 2005 | - | $1.26 M(-10.3%) | $4.40 M(+14.6%) |
| June 2005 | - | $1.41 M(+61.1%) | $3.84 M(+37.1%) |
| Mar 2005 | - | $872.00 K(+1.0%) | $2.80 M(+10.7%) |
| Dec 2004 | $2.53 M(+47.8%) | $863.00 K(+23.3%) | $2.53 M(-8.8%) |
| Sept 2004 | - | $700.00 K(+91.8%) | $2.77 M(+33.7%) |
| June 2004 | - | $365.00 K(-39.4%) | $2.08 M(+11.9%) |
| Mar 2004 | - | $602.00 K(-45.7%) | $1.85 M(+8.4%) |
| Dec 2003 | $1.71 M(+17.3%) | $1.11 M(>+9900.0%) | $1.71 M(+183.4%) |
| Sept 2003 | - | $0.00(-100.0%) | $604.00 K(0.0%) |
| June 2003 | - | $145.00 K(-68.4%) | $604.00 K(+31.6%) |
| Mar 2003 | - | $459.00 K(+129.5%) | $459.00 K(+129.5%) |
| Dec 2002 | $1.46 M(+15.0%) | - | - |
| Dec 2001 | $1.27 M(+14.1%) | - | - |
| Dec 2000 | $1.11 M(-7.8%) | - | - |
| Dec 1999 | $1.21 M(+15.9%) | - | - |
| Dec 1998 | $1.04 M(+48.7%) | - | - |
| Mar 1998 | - | $200.00 K(0.0%) | $200.00 K(0.0%) |
| Dec 1997 | $700.00 K(-22.2%) | - | - |
| Dec 1996 | $900.00 K | - | - |
| Mar 1996 | - | $200.00 K | $200.00 K |
FAQ
- What is Avadel Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual D&A year-on-year change?
- What is Avadel Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly D&A year-on-year change?
- What is Avadel Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM D&A year-on-year change?
What is Avadel Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AVDL is $1.77 M
What is the all time high annual D&A for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual depreciation & amortization is $14.49 M
What is Avadel Pharmaceuticals annual D&A year-on-year change?
Over the past year, AVDL annual depreciation & amortization has changed by +$273.00 K (+18.29%)
What is Avadel Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AVDL is $1.03 M
What is the all time high quarterly D&A for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly depreciation & amortization is $3.93 M
What is Avadel Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AVDL quarterly depreciation & amortization has changed by +$1.05 M (+5850.00%)
What is Avadel Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AVDL is $2.00 M
What is the all time high TTM D&A for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM depreciation & amortization is $14.89 M
What is Avadel Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AVDL TTM depreciation & amortization has changed by +$229.00 K (+12.97%)